CRISPR/Cas9 technology inserted two stop codons (TAGTAA) into the C666 site in exon 2. This mimics the hot-spot mutation at the C649 site of human patients with paroxysmal kinesigenic dyskinesia. Normal levels of transcripts are seen in the brain, however complete loss of protein is seen, indicating a loss-of-function mutation. (J:255335)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count